---
title: "Von Hippel Lindau"
---
2 or more CNS HGBLs; or 1 HGBL + visceral lesion or retinal hemorrhage
Location
HGBLs in VHL in 60-80% of patients
Typically multiple
40-50% in spinal cord (posterior half)
44-72% cerebellum (posterior &gt; anterior half)
10-25% brainstem (posterior medulla)
1% supratentorial (along optic pathways, in cerebral hemispheres)
Ocular angiomas
Found in 25-60% of VHL gene carriers
Cause retinal detachment, hemorrhage
Cystadenoma of endolymphatic sac (ELS)
Large; located posterior to internal auditory canal
Size
HGBLs vary from tiny mass to very large with even larger associated cysts

angiomatosis, hemangioblastomas of brain stem, cerebellum or spinal cord, multiple pheochromocytoma, renal cell carcinoma bilateral or multifocal, pancreatic cysts (pancreatic serous cystadenoma), endolymphatic sac tumor, and bilateral papillary cystadenomas of the epididymis (men) or broad ligament of the uterus (women).
Mutations of the von Hippel-Lindau tumor suppressor (VHL) gene on the short arm of chromosome 3 (3p25-26)

Autosomal dominant
Renal: Clear cell RCC (25-50%), Cysts
Pancreas: Cysts, Serous cystadenoma, neuroendocrine tumors
Adrenal: Pheochromocytoma (often multiple)
CNS: Hemangioblastoma (cerebellum, brain stem, spinal cord); Endolymphatic sac tumors

